Multi-indication drugs open new possibilities for pharmaceutical marketing but also bring unique challenges. Approved for multiple conditions, these treatments require a targeted, data-driven strategy to unlock their full potential across diverse therapeutic areas. In Japan, traditional sales and distribution data...

Drawing from recent conversations with Australian healthcare innovators, including discussions at AusBiotech 2024, Dr. Peter Cronin explores the evolving challenges of US market entry. He shares insights on how companies are moving beyond traditional approaches to embrace data-driven, patient-centric strategies...

The ability to see and act on facility-level insights is not just an advantage – it's a necessity. With Prospection AI and Facility Insights, pharmaceutical companies are equipped to treat patients with greater precision and confidence, driving both business success...

Patient-centric intelligence (PCI) offers Australian biotech and medical device companies a powerful tool for navigating the US healthcare market. Discover how PCI can unlock market potential, mitigate risks, and strengthen pitches to partners and investors.

Learn how Patient-Centric Intelligence (PCI) platforms can enhance collaborative brand management in the pharmaceutical industry. By integrating data and fostering cross-functional teamwork, PCI platforms empower teams to make informed decisions that improve patient outcomes and optimise brand performance. Discover how...

Prospection is opening an Analytics Center of Excellence (ACE) in India, tapping into the country's reputation as a global analytics powerhouse. This strategic move will strengthen our ability to deliver patient-centric intelligence to life sciences companies across the U.S., Japan,...

Patient-centric intelligence can be utilised in early phases of pharma product development lifecycle for identification of unmet medical needs and opportunities and to improve the success rate of clinical trials, leading to faster drug development, successful market entry and treatments...